Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00720759 · ClinicalTrials.gov registry record · Phase 2
Improving Stroke Rehabilitation: Spacing Effect and D-cycloserine
A Phase 2 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
NCT00720759 is a Phase 2 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 24 participants.
The verdict
NCT00720759, a Phase 2 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
Study Summary
Each year 730,000 Americans experience a stroke. Forty percent are left with significant paralysis of one arm. Certain types of physical therapy, for example constraint induced movement therapy (CIMT), have been shown to be effective in improving arm function. However, for most subjects, improvement is modest. In this trial, we test two approaches that may increase the amount of improvement achieved: 1) distributing treatment over a greater amount of time; and 2) adding a drug, d-cycloserine, which theoretically enhances the molecular mechanisms of learning.
Interventions
- DRUG D-cycloserine + distributed treatment
- BEHAVIORAL D-cycloserine + condensed treatment
- DRUG Placebo + distributed treatment
- BEHAVIORAL Placebo + condensed treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2009-07 |
| Est. Completion | 2011-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00720759
The ClinicalTrials.gov registry entry for NCT00720759 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which D-cycloserine + distributed treatment is the first listed.
NCT00720759 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00720759 about?
NCT00720759 is a clinical study titled "Improving Stroke Rehabilitation: Spacing Effect and D-cycloserine". Each year 730,000 Americans experience a stroke. Forty percent are left with significant paralysis of one arm. Certain types of physical therapy, for example constraint induced movement therapy (CIMT), have been shown to be effective in improving arm function. However, for most subjects, improvement...
What is the current status of trial NCT00720759?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2009-07. Estimated completion is 2011-11.
What interventions are being tested in trial NCT00720759?
The interventions under investigation include: D-cycloserine + distributed treatment (DRUG), D-cycloserine + condensed treatment (BEHAVIORAL), Placebo + distributed treatment (DRUG), Placebo + condensed treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT00720759?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.